Showing results (161-170 of 214) with videos related to

Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a phase I studyM Beran, S Jeha, S O'Brien, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1991
Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purgingB Calabretta, R B Sims, M Valtieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemiaS M O'Brien, H M Kantarjian, J Cortes, et al.
Leukemia & Lymphoma|June 1, 1993
Phase II clinical trial of fludarabine in chronic lymphocytic leukemia on a weekly low-dose scheduleA Kemena, S O'Brien, H Kantarjian, et al.
Nature|February 12, 1987
A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemiaR Kurzrock, M Shtalrid, P Romero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1985
A characteristic pattern of leukemic cell differentiation without cytoreduction during remission induction in acute promyelocytic leukemiaH M Kantarjian, M J Keating, K B McCredie, et al.
Pageof 22